News

To curb further spread of Ebola in Sierra Leone, a team of scientists that is part of an international, multi-organizational effort has released their first dataset of the virus’ genetic structure online.

As the 100,000 Genomes Project moves into Phase 3 Congenica has been named as a platform provider.

Researchers have developed a rapid, scalable, and cost-effective method for chromosomal phasing that provides researchers with a new method to determine if genetic variants are linked on the same chromosome.

This partnership sets out to develop cell-free DNA (cfDNA) reference standards.

For the first time, Deutsche Messe is staging BIOTECHNICA in conjunction with the new LABVOLUTION to attract an even wider industry audience to Hannover from 6 to 8 October 2015.

Investigators at the NIH have announced a series of clinical trials that will study drugs or drug combinations that target specific genetic mutations.

Test is first-to-market, non-invasive IVD assay for reliable detection of both Helicobacter pylori and clarithromycin resistance from stool sample.

Scientists have engineered E.coli to generate new varieties one of the most commonly used antibiotics, Erythromycin.

Collaboration will contribute to further refinement of diagnostic SNPs for Alzheimer’s disease.

Collaboration for blood-based molecular testing services and products to support the development of precision medicine in oncology.